Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner
Genetic Tests for Cancer

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.


1. Secretary's Advisory Committee on Genetic Testing. Department of Health and Human Services. Request for public comment on a proposed classification methodology for determining level of review for genetic tests. Federal Register 2000:65(236):76643-45.

2. New frontiers in grey literature: GL'99 proceedings. Fourth International Conference on Grey Literature. Washington, D.C.: GreyNet; 1999.

3. Alberani V, De Castro Pietrangeli P, Mazza AM. The use of grey literature in health sciences: a preliminary survey. Bull Med Libr Assoc 1990;78:358-63.

4. Baker M. In biomarkers we trust? Nat Biotechnol 2005;23:297-304.

5. NLM. National Library of Medicine's Health Technology Assessment Information Resources.; 2005.

6. NCI. The Early Detection Research Network: Translational Research to Identify Early Cancer and Cancer Risk. 2005; Third Report.

Return to Contents


Prepared for the Agency for Healthcare Research and Quality (Contract No. 290-02-0022).

Kevin M. Chin, MD, MS; Benjamin Wessler, BA; Priscilla Chew, MPH; and Joseph Lau, MD

Tufts-New England Medical Center Evidence-based Practice Center

750 Washington Street, NEMC #63
Boston, MA 02111
Phone: 617-636-0734
Fax: 617-636-8628

This report is based on research conducted by the Tufts-New England Medical Center Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0022). The findings and conclusions in this document are those of the author(s) who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services.

The information in this report is intended to help health care decision-makers; patients and clinicians, health system leaders, and policymakers, make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients.

Acknowledgments: The authors would like to thank AHRQ Task Order Officer, Dr. Gurvaneet Randhawa, for his invaluable contributions throughout the process of producing this technology assessment.

Return to Contents

The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care